Skip to content

  1. Tada’s $4 billion Psoriasis pill helps clear skin in mid-stage study.Bloomberg
  2. In retrospect, we say this was a bargain. Takeda reveals first data from $4 billion autoimmune disease pillThe Boston Globe
  3. Takeda raised by BofA to buy on growth prospects and debt repayment (NYSE:TAK)Seeking Alpha
  4. See full coverage on Google News

[ad_2]